Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Monmouth Junction, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page
25
Current page
36
DEFA14A File 000-28489

DEFA14A

Filing date
04 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 000-28489

DEFR14A

Filing date
04 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-28489

DEFA14A

Filing date
23 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-28489

DEFA14A

Filing date
23 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 000-28489

DEFR14A

Filing date
22 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-188637

FORM S-1

Filing date
15 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

424B3

Filing date
14 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-28489

DEFA14A

Filing date
14 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28489

FORM 8-K

Filing date
08 May 2013
Reporting date
26 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
06 May 2013
Reporting date
03 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-28489

DEFA14A

Filing date
30 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-28489

DEF 14A

Filing date
30 Apr 2013
Reporting date
05 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

424B3

Filing date
24 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-28489

PRE 14A

Filing date
18 Apr 2013
Reporting date
18 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

424B3

Filing date
09 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

424B3

Filing date
26 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-184929

424B3

Filing date
26 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-28489

FORM 10-Q

Filing date
25 Mar 2013
Reporting date
31 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-28489

NT 10-Q

Filing date
18 Mar 2013
Reporting date
31 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

424B3

Filing date
07 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-184929

424B3

Filing date
07 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28489

8-K

Filing date
07 Mar 2013
Reporting date
06 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28489

8-K

Filing date
06 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185357

FORM 424B3

Filing date
04 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .